Chromic Chloride
drugOn this page
Also known as Chromic chloride anhydrousChromic chloride hexahydrateChromium (as chromic chloride)Chromium (iii) chlorideChromium chloride (crcl3)Chromium(iii) chloride, anhydrousChromium(III) Chloride
Summary
Chromic Chloride (CHEMBL1200528) is an approved small molecule.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Small molecule
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1200528 |
| Name | Chromic Chloride |
| Type | Small molecule |
| Max phase | 4 |
Also known as: Chromic chloride, Chromic chloride anhydrous, Chromic chloride hexahydrate, Chromium (as chromic chloride), Chromium (iii) chloride, Chromium chloride (crcl3), Chromium(iii) chloride, anhydrous, CHROMIC CHLORIDE, Chromium(III) Chloride
Targets
Targets
Broader ChEMBL bioactivity targets: 2 (assay-derived). Sample: Tyrosine-protein kinase Fyn, Epidermal growth factor receptor.
Bioactivity
ChEMBL activities: 2 potent at pChembl ≥ 5 of 2 total. Top 30 by potency (10 = 0.1 nM, 6 = 1 µM):
| Target | pChembl | Type | Value | Unit | Activity ID |
|---|---|---|---|---|---|
| FYN | 5.76 | IC50 | 1750 | nM | CHEMBL_ACT_7679920 |
| EGFR | 5.53 | IC50 | 2955 | nM | CHEMBL_ACT_7679918 |
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indications (0 at ChEMBL trial phase 4).
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.